Szekeres-Bartho J et al. Interaction of progesterone- and cytokine-mediated immunomodulatory mechanisms in favour of successful gestation.. (1995) REGIONAL IMMUNOLOGY 0896-0623 6 315-319,
1357074
Laskarin G et al. Progesterone directly and indirectly affects perforin expression in cytolytic cells.. (1999) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 42 5 312-320
SZEKERESBARTHO J et al. THE EXPRESSION OF A PROGESTERONE-INDUCED IMMUNOMODULATORY PROTEIN IN PREGNANCY LYMPHOCYTES. (1995) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 34 6 342-348,
1356456
Sahin Mefkure Eraslan et al. The role of serum progesterone induced blocking factor on unexplained infertility. (2020) EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY 0301-2115 1872-7654 252 15-18
Díaz P. et al. Review of the usefulness of progesterone use in unexplained recurrent miscarriage. (2019) REVISTA CHILENA DE OBSTETRICIA Y GINECOLOGÍA 0048-766X 0717-7526 84 6 526-530
Sahin E. et al. High immunoexpression of progesterone-induced blocking factor (PIBF) in endometrial cancer. (2019) EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY 0392-2936 40 1 80-83
Uebelhoer Luke S et al. CD4+T Cell Activation During the Newborn Period: Barriers Against and Pathways Toward Th1 Immunity. (2018) CRITICAL REVIEWS IN IMMUNOLOGY 1040-8401 38 1 75-89
Tiwari Diptika et al. Preterm delivery and associated negative pregnancy outcome - A tale of faulty progesterone receptor signalling pathway and linked derailed immunomodulation: A study from Northeast India. (2016) JOURNAL OF REPRODUCTIVE IMMUNOLOGY 0165-0378 118 76-84
Check JH. The importance of up and down regulation of receptors for FSH, progesterone and the gonadotropin releasing hormone (GnRH)in the ovary, endometrium and lymphocytes in correcting various ovulatory disorders and achieving live deliveries. (2013) Megjelent: Ovulation: Detection, Signs/Symptoms and Outcomes pp. 1-42
Amir D et al. BOOTS FOR ACHILLES: PROGESTERONE'S REDUCTION OF CHOLESTEROL IS A SECOND-ORDER ADAPTATION. (2013) QUARTERLY REVIEW OF BIOLOGY 0033-5770 1539-7718 88 2 97-116
Diantonio A et al. One step closer to the development of a rapid bioassay to determine if adequate luteal phase progesterone supplementation is provided during in vitro fertilization-embryo transfer cycles. (2011) Megjelent: 16TH WORLD CONGRESS ON IN VITRO FERTILIZATION AND THE 5TH WORLD CONGRESS ON IN VITRO MATURATION pp. 57-60
Kyurkchiev D et al. Immunoregulation by progesterone: Effects on immune cells and mesenchymal stem cells. (2011) ADVANCES IN NEUROIMMUNE BIOLOGY 1878-948X 1878-9498 1 2 102-123
Bose PD et al. High viral load and deregulation of the progesterone receptor signaling pathway: Association with Hepatitis E-related poor pregnancy outcome. (2011) JOURNAL OF HEPATOLOGY 0168-8278 1600-0641 54 6 1107-1113
Kyurkchiev DS et al. EFFECT OF PROGESTERONE ON HUMAN MESENCHYMAL STEM CELLS. (2011) VITAMINS AND HORMONES-ADVANCES IN RESEARCH AND APPLICATIONS 0083-6729 87 217-237
Hel Z et al. Sex Steroid Hormones, Hormonal Contraception, and the Immunobiology of Human Immunodeficiency Virus-1 Infection. (2010) ENDOCRINE REVIEWS 0163-769X 1945-7189 31 1 79-97
Check JH et al. Progesterone Receptor Antagonist Therapy Has Therapeutic Potential Even in Cancer Restricted to Males as Evidenced from Murine Testicular and Prostate Cancer Studies. (2010) ANTICANCER RESEARCH 0250-7005 1791-7530 30 12 4921-4923
Kyurkchiev D et al. New target cells of the immunomodulatory effects of progesterone. (2010) REPRODUCTIVE BIOMEDICINE ONLINE: AN INTERNATIONAL JOURNAL DEVOTED TO BIOMEDICAL RESEARCH ON HUMAN CONCEPTION AND THE WELFARE OF THE HUMAN EMBRYO 1472-6483 1472-6491 21 3 304-311
Check JH et al. Mifepristone Treatment Improves Length and Quality of Survival of Mice with Spontaneous Lung Cancer. (2010) ANTICANCER RESEARCH 0250-7005 1791-7530 30 1 119-122
Check JH et al. Efficacy of the Progesterone Receptor Antagonist Mifepristone for Palliative Therapy of Patients with a Variety of Advanced Cancer Types. (2010) ANTICANCER RESEARCH 0250-7005 1791-7530 30 2 623-628
Check JH. A practical approach to the prevention of miscarriage: Part 2-active immunotherapy. (2010) CLINICAL & EXPERIMENTAL OBSTETRICS & GYNECOLOGY 0390-6663 37 1 5-9
Check JH et al. Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein. (2009) MEDICAL HYPOTHESES 0306-9877 1532-2777 72 1 87-90
Check JH et al. Mifepristone Treatment Improves Length and Quality of Survival of Mice with Spontaneous Leukemia. (2009) ANTICANCER RESEARCH 0250-7005 1791-7530 29 8 2977-2980
Check JH. A practical approach to the prevention of miscarriage: Part 1-progesterone therapy. (2009) CLINICAL & EXPERIMENTAL OBSTETRICS & GYNECOLOGY 0390-6663 36 4 203-208
Walch KT et al. Progesterone for recurrent miscarriage: truth and deceptions. (2008) BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY 1521-6934 1532-1932 22 2 375-389
Kyurkchiev D et al. Female sex steroid hormones modify some regulatory properties of monocyte-derived dendritic cells. (2007) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 58 5 425-433
Srivastava MD et al. Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. (2007) LEUKEMIA & LYMPHOMA 1042-8194 1029-2403 48 8 1610-1617
Check JH et al. Evidence that progesterone receptor antagonists may help in the treatment of a variety of cancers by locally suppressing natural killer cell activity. (2007) CLINICAL & EXPERIMENTAL OBSTETRICS & GYNECOLOGY 0390-6663 34 4 207-211
Malik S. et al. Debate: Should progesterone supplements be used? - against. (2007) Megjelent: Recurrent Pregnancy Loss: Causes, Controversies and Treatment pp. 93-96
Nardo LG et al. Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles. (2006) REPRODUCTIVE BIOMEDICINE ONLINE: AN INTERNATIONAL JOURNAL DEVOTED TO BIOMEDICAL RESEARCH ON HUMAN CONCEPTION AND THE WELFARE OF THE HUMAN EMBRYO 1472-6483 1472-6491 13 1 47-57
Miranda S et al. Dendritic cells therapy confers a protective microenvironment in murine pregnancy.. (2006) SCANDINAVIAN JOURNAL OF IMMUNOLOGY 0300-9475 1365-3083 64 5 493-499
Porstmann J et al. Progesterone-induced blocking factor (PIBF) - The key to a successful pregnancy?. (2005) JOURNAL FUR FERTILITäT UND REPRODUKTION 1019-066X 15 3 7-11
Druckmann R et al. Progesterone and the immunology of pregnancy. (2005) JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 0960-0760 1879-1220 97 5 389-396
Check JH et al. Miscarriage in the first trimester according to the presence or absence of the progesterone-induced blocking factor at three to five weeks from conception in progesterone supplemented women. (2005) CLINICAL & EXPERIMENTAL OBSTETRICS & GYNECOLOGY 0390-6663 32 1 13-14
Check JH et al. Lymphocyte immunotherapy can improve pregnancy outcome following embryo transfer (ET) in patients failing to conceive after two previous ET. (2005) CLINICAL & EXPERIMENTAL OBSTETRICS & GYNECOLOGY 0390-6663 32 1 21-22
Nautiyal J et al. Mifepristone (Ru486) antagonizes monocyte chemotactic protein-3 down-regulation at early mouse pregnancy revealing immunomodulatory events in Ru486 induced abortion. (2004) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY AND MICROBIOLOGY 8755-8920 52 1 8-18
Lédée-Bataille N. Materno-foetal dialogue and embryo implantation: Some evoluting concepts. (2004) JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION 0368-2315 33 7 564-576
Obendorf M et al. Interactions of sex steroids with mechanisms of inflammation. (2004) CURRENT DRUG TARGETS INFLAMMATION AND ALLERGY 1568-010X 3 4 425-433
Joachim R et al. The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response.. (2003) STEROIDS 0039-128X 1878-5867 68 10-13 931-940
Sendag F et al. The changes of circulating lymphocyte sub-populations in women with preterm labour: a case-controlled study. (2002) AUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY 0004-8666 1479-828X 42 4 358-361
Check JH. Th1 and Th2 cytokine profiles in recurrent aborters may merely reflect the progesterone status. (2002) HUMAN REPRODUCTION 0268-1161 1460-2350 17 6 1669-1670
Seli E et al. Modulation of the immune system by sex steroids. (2002) INFERTILITY AND REPRODUCTIVE MEDICINE CLINICS OF NORTH AMERICA 1047-9422 13 1 19-48
Corrado F et al. A randomised trial of progesterone prophylaxis after midtrimester amniocentesis. (2002) EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY 0301-2115 1872-7654 100 2 196-198
Check JH et al. A model for potential tumor immunotherapy based on knowledge of immune mechanisms responsible for spontaneous abortion. (2001) MEDICAL HYPOTHESES 0306-9877 1532-2777 57 3 337-343
Singh AK et al. Lupus nephritis and the anti-phospholipid antibody syndrome in pregnancy. (2000) KIDNEY INTERNATIONAL 0085-2538 1523-1755 58 5 2240-2254
Oleszczuk J et al. Alterations in the immune system of patients with imminent preterm labour. (2000) GYNECOLOGIC AND OBSTETRIC INVESTIGATION 0378-7346 1423-002X 49 2 110-113
Eblen AC et al. Alterations in humoral immune responses associated with recurrent pregnancy loss. (2000) FERTILITY AND STERILITY 0015-0282 73 2 305-313
Fukui K et al. Leukocyte function-associated antigen-1 expression on decidual natural killer cells in patients with early pregnancy loss. (1999) MOLECULAR HUMAN REPRODUCTION 1360-9947 1460-2407 5 11 1083-1088
Aranha C et al. Isolation and purification of an early pregnancy factor-like molecule from culture supernatants obtained from lymphocytes of pregnant women. (1998) JOURNAL OF ASSISTED REPRODUCTION AND GENETICS 1058-0468 15 3 117-124
Arck PC et al. Murine T cell determination of pregnancy outcome: I. Effects of strain, αβ T cell receptor, γδ T cell receptor, and γδ T cell subsets. (1997) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY AND MICROBIOLOGY 8755-8920 37 6 492-502
Check JH et al. 52nd Annual Meeting of the American Society for Reproductive Medicine, Boston, Massachusetts, 2-6 November 1996: Expression of an immunomodulatory protein known as progesterone induced blocking factor (PIBF) does not correlate with first trimester spontaneous abortions in progesterone supplemented women. (1997) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 37 4 330-334
SzekeresBartho J et al. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. (1996) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 35 4 348-351,
1356455
Barth C. et al. Towards an understanding of women's brain aging: the immunology of pregnancy and menopause. (2020) FRONTIERS IN NEUROENDOCRINOLOGY 0091-3022 1095-6808 58
Sahin Mefkure Eraslan et al. The role of serum progesterone induced blocking factor on unexplained infertility. (2020) EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY 0301-2115 1872-7654 252 15-18
Fulop Vilmos et al. The relationship between inflammatory and immunological processes during pregnancy. (2019) ORVOSI HETILAP 0030-6002 1788-6120 160 32 1247-1259
Sahin E. et al. High immunoexpression of progesterone-induced blocking factor (PIBF) in endometrial cancer. (2019) EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY 0392-2936 40 1 80-83
Milkowska Karolina et al. Disgust sensitivity in relation to menstrual cycle phase in women with and without an infection. (2019) AMERICAN JOURNAL OF HUMAN BIOLOGY 1042-0533 1520-6300 31 3
Zumwalde NA et al. Modeling human antitumor responses in vivo using umbilical cord blood-engrafted mice. (2018) FRONTIERS IN IMMUNOLOGY 1664-3224 9 JAN
Littauer Elizabeth Q. et al. Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy. (2018) FRONTIERS IN IMMUNOLOGY 1664-3224 9
Madendag Yusuf et al. High Immune Expression of Progesterone-Induced Blocking Factor in Epithelial Ovarian Cancer. (2018) TECHNOLOGY IN CANCER RESEARCH & TREATMENT 1533-0346 17
Schumacher Anne et al. Progesterone-driven local regulatory T cell induction does not prevent fetal loss in the CBA/JxDBA/2J abortion-prone model. (2017) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 77 3
Renz Harald et al. An exposome perspective: Early-life events and immune development in a changing world. (2017) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 0091-6749 1097-6825 140 1 24-40
Chaudhuri S. Development of human immune system in first and second trimester. (2016) Megjelent: Human Fetal Growth and Development: First and Second Trimesters pp. 305-318
Wolfson Manuel et al. Lipopolysaccharide-induced murine embryonic resorption involves changes in endocannabinoid profiling and alters progesterone secretion and inflammatory response by a CB1-mediated fashion. (2015) MOLECULAR AND CELLULAR ENDOCRINOLOGY 0303-7207 1872-8057 411 C 214-222
Торчинов А.М. et al. The combined therapy for the first trimester retrochorial hematoma in patients with pregnancy loss. (2014) Problemy reproduktsii 1025-7217 1 82-86
Bartmann C et al. Quantification of the Predominant Immune Cell Populations in Decidua Throughout Human Pregnancy. (2014) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 71 2 109-119
